Roman Drai | Director, Clinical Development
Geropharm

Roman Drai, Director, Clinical Development, Geropharm

Establishing clinical development strategy from the pre-IND setting to pivotal trials and registration with focus on biosimilars of insulin and insulin analogues.

Successfully performed several clinical trials including hyperinsulinemic euglycemic clamps and bioequivalence, Phase III trials. Incorporates elements of Risk Based Monitoring into clinical trials department at GEROPHARM.

Has joined clinical trials since Jan 2011. Worked in Quintiles in Endocrinology, Rheumatology, Cardiovascular, Oncology trials.

MD, PhD in the field of medicine. Experienced as a research fellow in preclinical studies (3 years in gastroenterology, 1 year in respiratory diseases, rheumatology, in diabetes mellitus, metabolic syndrome, acute pancreatitis, multiple sclerosis).

Appearances:



Biosimilars Day 1 - Monday 29th October 2018 @ 14:10

Case Study: Biosimilar development in Russia and EuroAsian Union

Biosimilars Day 1 - Monday 29th October 2018 @ 17:30

Panel discussion: How can we best converge strategies and regulatory environments to market a biosimilar in an emerging market country in the future?

last published: 29/Oct/18 16:25 GMT
last published: 29/Oct/18 16:25 GMT

back to speakers

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.

 

Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates